Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Vitamin K epoxide reductase (VKOR) is an integral membrane enzyme crucial for the vitamin K cycle. It catalyzes the reduction of vitamin K 2,3-epoxide and vitamin K to vitamin K hydroquinone, which is a necessary cofactor for the gamma-glutamyl carboxylation of specific proteins, most notably those involved in blood coagulation. VKOR is highly sensitive to inhibition by warfarin—the most widely prescribed oral anticoagulant.
Inhibition of Vitamin K epoxide reductase
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vitamin K epoxide reductase (VKOR).